Candida auris (C. auris) is a dangerous drug-resistant fungal pathogen emerging in U.S. hospitalsTafenoquine’s presumed mode of action against C. auris is differentiated from standard of care treatmentMonash University will conduct the studies beginning in second quarter of 2024 WASHINGTON, Feb. 20, 2024 (GLOBE NEWSWIRE) 60 Degrees Pharmaceuticals, Inc. (the “Company,” “60P” or “60 Degrees Pharmaceuticals”) (NASDAQ: SXTP; SXTPW), specialists in developing and marketing medicines for infectiou
By Stacy M. Brown NNPA Newswire Senior National Correspondent @StacyBrownMedia On the eve of World AIDS Day, the U.S. Centers for Disease Control and Prevention put out a call for urgency and a collective commitment to ending the HIV pandemic in America. Agency officials said while there has been recent progress in HIV prevention, the
Agency portrayed ivermectin as dangerous by conflating human and livestock dosages, but didn t take pains to warn providers Moderna jabs have "notably more" than authorized for kids.
60 Degrees Pharmaceuticals Suspends Phase IIB Study of Tafenoquine for COVID-19, Pivots to Refocus on Commercialization of Treatments for Malaria and Tick-Borne Diseases itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.